Role Of Calf Blood Hemodialysate In The Management Of Open Wounds

Authors: Sheeraz Shakoor Siddiqui, Muhammad Taqi Pirzada, Shams Nadeem Alam

1. CIVIL HOSPITAL & DOW UNIVERSITY OF HEALTH SCIENCES, KARACHI.
2. CIVIL HOSPITAL & DOW UNIVERSITY OF HEALTH SCIENCES, KARACHI.
3. CIVIL HOSPITAL & DOW UNIVERSITY OF HEALTH SCIENCES, KARACHI.

Volume 32 | Issue 3

Published: October 29, 2026

Abstract

To determine the role of calf blood hemodialysate in the management of open wounds.
Design: Descriptive; Quasi-experimental. Methods: A total of 39 open granulating wounds of myriad etiologies were treated with calf blood hemodialysate between January 2019 and December 2024. The response to treatment was documented for: wound contraction; change of depth; complications; and, time to definitive healing/closure. Results: Mean decrease in wound length was: abdomen-0.8 cm; extremity-2.3 cm; post-abscess-4.3 cm. Mean decrease in depth was: abdomen-0.5 cm; extremity-0.2cm; post-abscess-1.4cm. Duration of healing was highest for extremity wounds (mean: 22.8 days). Four patients developed a local allergic reaction to the hemodilysate. Conclusion: Calf blood hemodialysate augments the healing process and has a positive impact on healing of open wounds.

Keywords: hemodialysate; Solcoseryl; hexosylceramide.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)